Skip to Content
COVID-19 Resources
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 09/13/21

Head & Neck SPOREs

SPOREs in head and neck cancer support translational research on cancers of the upper aero-digestive tract. In 2018, approximately 396,937 people in the United States were living with oral cavity and oropharyngeal cancer and 96,022 with laryngeal cancer. In 2020, it is estimated that there will be 54,010 new cases of oral cavity and oropharyngeal cancer and an estimated 10,850 deaths. For laryngeal cancer, approximately 12,620 new cases and 3,770 deaths are estimated. Known risk factors for head & neck cancer include smoking, alcohol use, and human papillomavirus (HPV) infection. The first SPOREs in head and neck cancer were established in 2002, and co-funding for this program is received by the National Institute of Dental and Craniofacial Research.